X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2719) 2719
science & technology (2267) 2267
life sciences & biomedicine (2229) 2229
androstadienes - therapeutic use (1958) 1958
female (1847) 1847
fluticasone (1542) 1542
male (1477) 1477
androstadienes - administration & dosage (1154) 1154
middle aged (1056) 1056
adult (1052) 1052
asthma - drug therapy (867) 867
aged (729) 729
administration, inhalation (710) 710
treatment outcome (696) 696
androstadienes - pharmacology (614) 614
double-blind method (589) 589
asthma (568) 568
adolescent (532) 532
breast neoplasms - drug therapy (528) 528
androstadienes - adverse effects (526) 526
albuterol - analogs & derivatives (512) 512
respiratory system (507) 507
anti-inflammatory agents - therapeutic use (481) 481
abridged index medicus (455) 455
bronchodilator agents - therapeutic use (452) 452
child (448) 448
albuterol - therapeutic use (437) 437
oncology (437) 437
animals (431) 431
pharmacology & pharmacy (399) 399
drug combinations (364) 364
anti-asthmatic agents - therapeutic use (358) 358
allergy (355) 355
drug therapy, combination (342) 342
drug therapy (329) 329
immunology (324) 324
salmeterol xinafoate (324) 324
breast cancer (323) 323
bronchodilator agents - administration & dosage (317) 317
corticosteroids (292) 292
fluticasone propionate (290) 290
general & internal medicine (286) 286
anti-inflammatory agents - administration & dosage (274) 274
pulmonary disease, chronic obstructive - drug therapy (274) 274
aromatase inhibitors - therapeutic use (270) 270
asthma - physiopathology (266) 266
care and treatment (246) 246
dose-response relationship, drug (246) 246
albuterol - administration & dosage (245) 245
anti-asthmatic agents - administration & dosage (240) 240
aged, 80 and over (234) 234
antineoplastic agents - therapeutic use (229) 229
analysis (221) 221
postmenopause (220) 220
time factors (215) 215
tamoxifen - therapeutic use (211) 211
fluticasone-salmeterol drug combination (208) 208
breast neoplasms - pathology (204) 204
drug administration schedule (201) 201
antineoplastic agents, hormonal - therapeutic use (198) 198
research (197) 197
administration, intranasal (190) 190
nitriles - therapeutic use (189) 189
steroids (188) 188
triazoles - therapeutic use (187) 187
randomized controlled trials as topic (183) 183
aromatase inhibitors (181) 181
child, preschool (179) 179
medicine, general & internal (179) 179
quality of life (177) 177
cross-over studies (174) 174
antineoplastic combined chemotherapy protocols - therapeutic use (172) 172
administration, topical (171) 171
glucocorticoids - therapeutic use (171) 171
rats (168) 168
exemestane (165) 165
cancer (161) 161
forced expiratory volume - drug effects (158) 158
health aspects (158) 158
glucocorticoids (157) 157
androstadienes - pharmacokinetics (155) 155
phosphatidylinositol 3-kinases - antagonists & inhibitors (154) 154
medicine & public health (152) 152
salmeterol (152) 152
anti-allergic agents - therapeutic use (150) 150
adrenal cortex hormones - therapeutic use (148) 148
clinical trials (146) 146
young adult (146) 146
phosphatidylinositol 3-kinases - metabolism (144) 144
budesonide - therapeutic use (143) 143
mice (142) 142
prospective studies (140) 140
retrospective studies (138) 138
rhinitis, allergic, seasonal - drug therapy (137) 137
glucocorticoids - administration & dosage (135) 135
respiratory function tests (135) 135
forced expiratory volume (134) 134
adrenal cortex hormones - administration & dosage (133) 133
nebulizers and vaporizers (133) 133
chronic obstructive pulmonary disease (130) 130
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2887) 2887
French (33) 33
Japanese (33) 33
German (24) 24
Chinese (23) 23
Italian (13) 13
Russian (12) 12
Spanish (12) 12
Dutch (9) 9
Polish (5) 5
Portuguese (4) 4
Hungarian (3) 3
Swedish (3) 3
Norwegian (2) 2
Romanian (2) 2
Croatian (1) 1
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 496 - 503
Summary In March, 2010, a group of breast cancer experts met to develop a consensus statement on breast cancer prevention, with a focus on medical and therapeutic interventions... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Thiophenes - therapeutic use | Metformin - therapeutic use | Raloxifene Hydrochloride - therapeutic use | Humans | Selective Estrogen Receptor Modulators - adverse effects | Tetrahydronaphthalenes - therapeutic use | Pyrrolidines - therapeutic use | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Estrogen Receptor Modulators - therapeutic use | Retinoids - therapeutic use | Selective Estrogen Receptor Modulators - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Female | Aromatase Inhibitors - therapeutic use | Estrogen Receptor Modulators - adverse effects | Anticarcinogenic Agents - therapeutic use | Triazoles - therapeutic use | Premenopause | Anastrozole | Consensus Development Conferences as Topic | Breast Neoplasms - prevention & control | Fenretinide - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Piperidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Tamoxifen - therapeutic use | Androstadienes - therapeutic use | Expert Testimony | Norpregnenes - therapeutic use | Nitriles - therapeutic use | COX-2 inhibitors | Care and treatment | Aspirin | Oncology, Experimental | Menopause | Phosphonates | Breast cancer | Retinoids | Research | Tamoxifen | Prevention | Analysis | Health aspects | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2014, Volume 371, Issue 2, pp. 107 - 118
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 474 - 482
Summary Background Treatment of breast cancer with aromatase inhibitors is associated with damage to bones. NCIC CTG MA.27 was an open-label, phase 3,... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Triazoles - adverse effects | United States | Humans | Middle Aged | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Breast Neoplasms - enzymology | Time Factors | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Diphosphonates - therapeutic use | Postmenopause | Adult | Female | Neoplasms, Hormone-Dependent - enzymology | Bones of Lower Extremity - drug effects | Chemotherapy, Adjuvant | Aromatase Inhibitors - therapeutic use | Triazoles - therapeutic use | Bones of Lower Extremity - diagnostic imaging | Lumbar Vertebrae - diagnostic imaging | Anastrozole | Bone Density Conservation Agents - therapeutic use | Treatment Outcome | Lumbar Vertebrae - drug effects | Breast Neoplasms - drug therapy | Radiography | Canada | Bone Density - drug effects | Breast Neoplasms - pathology | Calcium - therapeutic use | Neoplasms, Hormone-Dependent - pathology | Aged | Androstadienes - therapeutic use | Neoplasms, Hormone-Dependent - drug therapy | Vitamin D - therapeutic use | Nitriles - adverse effects | Androstadienes - adverse effects | Dietary Supplements | Fractures, Bone - prevention & control | Nitriles - therapeutic use | Medical colleges | Bones | Breast cancer | Density | Analysis | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2015, Volume 372, Issue 5, pp. 436 - 446
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2007, Volume 356, Issue 8, pp. 775 - 789
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2013, Volume 368, Issue 2, pp. 138 - 148
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 04/2017, Volume 35, Issue 10, pp. 1061 - 1069